Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.
Discover the immune-modulating and respiratory benefits of herbal and dietary supplements like eucalyptol, ginseng, Echinacea ...
A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...
Researchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...
The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...
With its impressive health profile, it’s hard to beat green tea, which many say is the healthiest beverage you can drink. If ...
BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved BioArctic's partner Eisai's ...
Mark Giaquinto was diagnosed with Parkinson's disease five years ago and continues to combat the illness with a positive outlook.
In the end, I have to be my best advocate for my own care. It took years, but when I became my best advocate, serious change happened,” Choi says.
The blood–brain barrier is a highly selective shield that protects the brain from harmful substances in the bloodstream.
In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback